CANYON//SRAM Racing Investigates Shari Bossuyt’s Failed Anti-Doping Test
CANYON//SRAM Racing, a professional women’s cycling team, has released a statement regarding Shari Bossuyt’s failed anti-doping test. The test was carried out by the French Anti-Doping Agency AFLD after the third stage of the Tour de Normandie Féminin in Caen, France.
According to the team’s statement, Bossuyt’s A and B samples both revealed the presence of a prohibited substance called Bis-(4-cyanophenyl)methanol, which is a metabolite of Letrozole. Letrozole and its metabolites are listed on the World Anti-Doping Agency’s (WADA) worldwide Prohibited List.
In response to the failed test, CANYON//SRAM Racing has taken a zero-tolerance stance and has provisionally made Bossuyt non-active while waiting for the decision of the AFLD. The team emphasized that adherence to anti-doping rules is an essential part of all contracts between the team and its riders.
Team Manager Ronny Lauke commented on the situation, stating, “We have a clear zero-tolerance stance towards doping in sport. We are in contact with Shari and her manager and await the decision of the AFLD.” Bossuyt and her manager will be holding a press conference in Belgium on Monday, June 5th, to address the matter.
The team’s statement has raised concerns about the incident and the potential consequences for Bossuyt’s career. The investigation into the failed anti-doping test will provide further insight into the situation.
